Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload
- PMID: 795481
Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload
Similar articles
-
[Further experiences with iron-chelating therapy (desferrioxamine and ascorbic acid) in siderochromatosis and Cooley's disease].Minerva Med. 1978 Mar 17;69(13):811-21. Minerva Med. 1978. PMID: 643223 Italian. No abstract available.
-
Desferrioxamine-induced iron outputs in Cooley's anemia. Results and perspectives.Haematologica. 1981 Apr;66(2):196-207. Haematologica. 1981. PMID: 6791996 No abstract available.
-
Oral ascorbic acid and iron excretion in thalassemic children treated with desferrioxamine-methansulfonate (Desferal).Birth Defects Orig Artic Ser. 1988;23(5B):129-33. Birth Defects Orig Artic Ser. 1988. PMID: 3390535 No abstract available.
-
Iron overload and iron chelation therapy in thalassaemia and sickle cell haemoglobinopathies.Acta Haematol. 1987;78(2-3):206-11. doi: 10.1159/000205876. Acta Haematol. 1987. PMID: 3120473 Review.
-
Clinical management of beta-thalassemia.Tex Rep Biol Med. 1980-1981;40:355-64. Tex Rep Biol Med. 1980. PMID: 7034276 Review. No abstract available.
Cited by
-
Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.Eur J Clin Microbiol. 1983 Oct;2(5):426-31. doi: 10.1007/BF02013899. Eur J Clin Microbiol. 1983. PMID: 6416837
-
High dosage desferrioxamine therapy in a female patient with acquired aplastic anaemia and transfusion siderosis.Blut. 1986 Apr;52(4):211-9. doi: 10.1007/BF00321080. Blut. 1986. PMID: 3634632
-
Synergy between the iron chelator deferoxamine and the antimicrobial agents gentamicin, chloramphenicol, cefalothin, cefotiam and cefsulodin.Eur J Clin Microbiol. 1983 Oct;2(5):432-8. doi: 10.1007/BF02013900. Eur J Clin Microbiol. 1983. PMID: 6315421
-
Desferrioxamine mesylate for managing transfusional iron overload in people with transfusion-dependent thalassaemia.Cochrane Database Syst Rev. 2013 Aug 21;2013(8):CD004450. doi: 10.1002/14651858.CD004450.pub3. Cochrane Database Syst Rev. 2013. PMID: 23963793 Free PMC article.